Clinical trial
Famciclovir Pediatric Formulation in Children 1 to 12 Years of Age With Herpes…
NCT00098059 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00098059 |
|---|---|
| Title | Famciclovir Pediatric Formulation in Children 1 to 12 Years of Age With Herpes Simplex Infection |
| Official title | A Multicenter, Open-label, Single-arm, Two-step Study to Evaluate the Safety and Single-dose Pharmacokinetics of Famciclovir and Multiple-dose Safety After Administration of Famciclovir Oral Pediatric Formulation to Children 1 to 12 Years of Age With Herpes Simplex Infection |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Herpes Simplex |
| Intervention type | Drug |
| Interventions | Famciclovir |
| Enrollment | 74 |
| Start date | Feb 1, 2005 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Dec 3, 2004 |
| Last update posted | Apr 25, 2013 |
| Countries | Panama, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: